They investigated the expression in the TME of 3 Plexin-A4 ligands, namely Sema3A, Sema6A, and Sema6B, and found that none of them modulated CD8+ T cell infiltration into the tumor bed. The gene discussed is SEMA3A; the disease is neoplasm.